ALPS Advisors’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$517K Buy
+2,000
New +$532K ﹤0.01% 754
2025
Q4
Sell
-13,367
Closed -$2.36M 1039
2025
Q3
$2.36M Sell
13,367
-4,095
-23% -$613K 0.01% 351
2025
Q2
$2.4M Buy
17,462
+15,542
+809% +$2.28M 0.01% 339
2025
Q1
$346K Buy
+1,920
New +$323K ﹤0.01% 812
2024
Q4
Sell
-22,372
Closed -$4.07M 1022
2024
Q3
$4.07M Buy
22,372
+102
+0.5% +$19.7K 0.03% 258
2024
Q2
$4.09M Buy
+22,270
New +$3.74M 0.03% 248
2023
Q4
Sell
-20,620
Closed -$2.39M 994
2023
Q3
$2.39M Buy
20,620
+384
+2% +$46.8K 0.02% 299
2023
Q2
$2.38M Buy
20,236
+3,259
+19% +$333K 0.02% 282
2023
Q1
$1.36M Sell
16,977
-467
-3% -$36.7K 0.01% 381
2022
Q4
$1.38M Buy
17,444
+3,403
+24% +$253K 0.01% 378
2022
Q3
$979K Sell
14,041
-1,170
-8% -$84.5K 0.01% 473
2022
Q2
$999K Sell
15,211
-10,702
-41% -$666K 0.01% 476
2022
Q1
$1.72M Sell
25,913
-2,906
-10% -$181K 0.02% 246
2021
Q4
$2.02M Buy
28,819
+1,606
+6% +$93.5K 0.02% 288
2021
Q3
$1.42M Sell
27,213
-2,028
-7% -$120K 0.01% 355
2021
Q2
$1.99M Sell
29,241
-6,413
-18% -$448K 0.02% 330
2021
Q1
$2.75M Buy
35,654
+111
+0.3% +$8.07K 0.03% 226
2020
Q4
$2.13M Buy
35,543
+10,467
+42% +$523K 0.02% 260
2020
Q3
$1.08M Buy
25,076
+1,357
+6% +$58.9K 0.02% 346
2020
Q2
$982K Sell
23,719
-7,751
-25% -$373K 0.01% 316
2020
Q1
$1.36M Sell
31,470
-3,366
-10% -$176K 0.02% 242
2019
Q4
$1.93M Buy
34,836
+348
+1% +$17.1K 0.02% 230
2019
Q3
$1.2M Buy
34,488
+4,260
+14% +$190K 0.01% 273
2019
Q2
$1.22M Sell
30,228
-4,623
-13% -$151K 0.01% 286
2019
Q1
$1.15M Buy
34,851
+1,507
+5% +$35.5K 0.01% 297
2018
Q4
$693K Buy
+33,344
New +$698K 0.01% 396

Other funds holding KRYS